Involvement of BKCa and KV potassium channels in cAMP-induced vasodilatation: their insufficient function in genetic hypertension
Language English Country Czech Republic Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
24397812
DOI
10.33549/physiolres.932718
PII: 932718
Knihovny.cz E-resources
- MeSH
- Adrenergic beta-Agonists MeSH
- Cyclic AMP metabolism MeSH
- Vascular Resistance MeSH
- Potassium Channels, Voltage-Gated metabolism MeSH
- Hypertension genetics metabolism physiopathology MeSH
- Isoproterenol MeSH
- Blood Pressure MeSH
- NG-Nitroarginine Methyl Ester MeSH
- Rats, Inbred SHR MeSH
- Rats, Inbred WKY MeSH
- Nitric Oxide Synthase antagonists & inhibitors MeSH
- Large-Conductance Calcium-Activated Potassium Channel alpha Subunits metabolism MeSH
- Vasodilation * MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adrenergic beta-Agonists MeSH
- Cyclic AMP MeSH
- Potassium Channels, Voltage-Gated MeSH
- Isoproterenol MeSH
- Kcnma1 protein, rat MeSH Browser
- NG-Nitroarginine Methyl Ester MeSH
- Nitric Oxide Synthase MeSH
- Large-Conductance Calcium-Activated Potassium Channel alpha Subunits MeSH
Spontaneously hypertensive rats (SHR) are characterized by enhanced sympathetic vasoconstriction, whereas their vasodilator mechanisms are relatively attenuated compared to their high BP. The objective of our in vivo study was to evaluate whether the impaired function of BKCa and/or KV channels is responsible for abnormal cAMP-induced vasodilatation in genetic hypertension. Using conscious SHR and normotensive WKY rats we have shown that under the basal conditions cAMP overproduction elicited by the infusion of beta-adrenoceptor agonist (isoprenaline) caused a more pronounced decrease of baseline blood pressure (BP) in SHR compared to WKY rats. Isoprenaline infusion prevented BP rises induced by acute NO synthase blockade in both strains and it also completely abolished the fully developed BP response to NO synthase blockade. These cAMP-induced vasodilator effects were diminished by the inhibition of either BKCa or KV channels in SHR but simultaneous blockade of both K(+) channel types was necessary in WKY rats. Under basal conditions, the vasodilator action of both K(+) channels was enhanced in SHR compared to WKY rats. However, the overall contribution of K(+) channels to cAMP-induced vasodilator mechanisms is insufficient in genetic hypertension since a concurrent activation of both K(+) channels by cAMP overproduction is necessary for the prevention of BP rise elicited by acute NO/cGMP deficiency in SHR. This might be caused by less effective activation of these K(+) channels by cAMP in SHR. In conclusion, K(+) channels seem to have higher activity in SHR, but their vasodilator action cannot match sufficiently the augmented vasoconstriction in this hypertensive strain.
References provided by Crossref.org
Altered Balance between Vasoconstrictor and Vasodilator Systems in Experimental Hypertension